HTWR News Alert Heartware International (HTWR) 72.62 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Heartware International (HTWR) 72.62 $HTWR

Volcano Acquired by Royal Philips for $1.2B: What Wall Street's Saying
at The Street - Wed Dec 17, 2:20PM CST
Volcano Corp. shares surged more than 50% on Wednesday after Royal Philips agreed to acquire the medical technology company for $1.2 billion.
BSX: 13.13 (+0.07), SPNC: 34.50 (+0.59), ABT: 45.70 (-0.02), PHG: 29.39 (-0.06), MDT: 74.08 (+0.31), TRIV: 13.47 (-0.40), VOLC: 17.95 (+0.02), STJ: 66.67 (+0.67), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02), ELGX: 15.35 (-0.06), ATRC: 18.76 (+0.13), NVDQ: 16.90 (+0.55)

HeartWare Presentation At The Oppenheimer 25th Annual Healthcare Conference To Be Webcast
PR Newswire - Thu Dec 04, 11:35AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Oppenheimer 25th Annual Healthcare Conference at 10:20 a.m. EST on Wednesday, December 10, 2014. The conference is being held December 10-11, 2014 at the Crowne Plaza Hotel in New York City.
HTWR: 72.62 (+0.02)

Thoratec: At The Heart Of A Health-Related Investment Strategy
Robert Honeywill - at Seeking Alpha - Sun Nov 30, 3:48AM CST
About the headline It is my contention, for Western economies, we will enjoy far lower growth in the future than we have enjoyed over the last several decades. For investors, it is not an optimal strategy to adopt a "rising tide lifts all boats"...
SSH: 4.04 (+0.19), THOR: 32.81 (+0.74), HTWR: 72.62 (+0.02)

HeartWare Presentation At The Canaccord Genuity 2014 Medical Technology & Diagnostics Forum To Be Webcast
PR Newswire - Thu Nov 13, 11:11AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 2014 Medical Technology & Diagnostics Forum at 10:00 a.m. EST on Thursday, November 20, 2014. The one-day conference is being held at the Westin Grand Central, New York.
HTWR: 72.62 (+0.02)

Update: Heartware International Q3 2014 Earnings
Andy Batts - at Seeking Alpha - Sat Nov 08, 1:38PM CST

HTWR: 72.62 (+0.02)

HeartWare Presentation At The Credit Suisse 2014 Healthcare Conference To Be Webcast
PR Newswire - Fri Nov 07, 8:00AM CST
HeartWare International, Inc. (NASDAQ:HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Credit Suisse 2014 Healthcare Conference at 2:00 p.m. MST (4:00 pm EST) on Wednesday, November 12, 2014. The conference is being held November 10-13 at the Arizona Biltmore in Phoenix.
HTWR: 72.62 (+0.02)

Heartware International (HTWR) Downgraded From Hold to Sell
at The Street - Mon Nov 03, 8:38AM CST
Heartware International (HTWR) has been downgraded by TheStreet Ratings from Hold to Sell with a ratings score of D+.
HTWR: 72.62 (+0.02)

HeartWare International ups revenues by 25% in Q3
Seeking Alpha - at Seeking Alpha - Fri Oct 31, 12:26PM CDT

HTWR: 72.62 (+0.02)

Is Haemonetics (HAE) Poised to Beat on Q2 Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 5:15PM CDT
Haemonetics (HAE) has delivered positive earnings surprises in three of the past four quarters with an average beat of 1.9%
HAE: 38.11 (+0.30), HTWR: 72.62 (+0.02), HOLX: 26.89 (+0.10), HSP: 62.60 (-0.07)

Nasdaq stocks posting largest percentage decreases
AP - Thu Oct 30, 5:02PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
BBOX: 24.21 (+0.28), AFOP: 14.55 (+0.13), AMCC: 6.63 (+0.09), NSIT: 25.84 (+0.39), ARAY: 7.54 (+0.19), HTWR: 72.62 (+0.02), CCUR: 6.98 (unch), THRM: 38.25 (-0.11), RPXC: 13.64 (-0.22), BWEN: 5.67 (+0.11), PRXL: 56.48 (+0.57), AZPN: 36.69 (+0.28), BBSI: 28.34 (+0.38), CRUS: 23.60 (unch), ARCP: 8.33 (unch), PCRX: 92.09 (-1.79), XOOM: 17.70 (-0.03)

Heartware International's (HTWR) CEO Douglas Godshall on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 2:51PM CDT

HTWR: 72.62 (+0.02)

Heartware International (HTWR) Q3 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:55AM CDT

HTWR: 72.62 (+0.02)

Heartware beats by $0.01, misses on revenue
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 6:40AM CDT

HTWR: 72.62 (+0.02)

HeartWare International Reports $68.6 Million In Third Quarter 2014 Revenue; 25% Increase From Third Quarter 2013
PR Newswire - Thu Oct 30, 5:58AM CDT
HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $68.6 million for the third quarter ended September 30, 2014, a 25% increase compared to $54.8 million in revenue for the same period of 2013.
HTWR: 72.62 (+0.02)

Can Qiagen (QGEN) Surprise Earnings Estimates in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:17PM CDT
In Japan, Qiagen (QGEN) performed impressively in the first half of 2014 on a year-over-year basis.
QGEN: 23.20 (+0.09), HTWR: 72.62 (+0.02), HOLX: 26.89 (+0.10), HSP: 62.60 (-0.07)

Will Cardinal Health (CAH) Disappoint Earnings in Q1? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 5:10PM CDT
Our proven model does not conclusively show that Cardinal Health Inc. (CAH) is likely to beat earnings this quarter.
DSCI: 9.08 (+0.43), CAH: 82.07 (+0.15), HTWR: 72.62 (+0.02), HSIC: 137.87 (+0.15)

Will PerkinElmer (PKI) Disappoint This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 4:59PM CDT
PerkinElmer (PKI) has managed to perform decently across several product lines and also posted solid operating results in the previous quarter.
HTWR: 72.62 (+0.02), CRL: 63.59 (+0.33), HSIC: 137.87 (+0.15), PKI: 43.99 (-0.06)

Can Ecolab Inc. (ECL) Surprise This Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:58PM CDT
Our proven model does not conclusively show that Ecolab Inc. (ECL) is likely to beat earnings this quarter.
HTWR: 72.62 (+0.02), HOLX: 26.89 (+0.10), HSP: 62.60 (-0.07), ECL: 107.18 (-0.27)

Is LabCorp (LH) Likely to Disappoint Earnings in Q3? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 2:20PM CDT
Laboratory Corp. of America Holdings (LH) is scheduled to release its third-quarter 2014 results before the opening bell on Oct 28.
LH: 107.69 (+0.56), HTWR: 72.62 (+0.02), HOLX: 26.89 (+0.10), HSP: 62.60 (-0.07)

Will DENTSPLY (XRAY) Disappoint Earnings this Season?
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Governance Is Becoming Enterprise Infrastructure

Updated Category News Views 69

Governance Has Finally Reached the Engine Room Enterprise AI is no longer a shiny pilot parked in some innovation lab; it is creeping into business-critical work, and that changes the argument entirely. Frost & Sullivan’s latest analysis makes a sensible point that too many executives still resist: AI governance is becoming a strategic operating capability, not merely a...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading
Chicago Kertész Show Puts Photography's Quiet Giant First

Updated Category News Views 112

A fork, a plate, and a sharp eye can outlast plenty of louder art. Leica Gallery Chicago is putting that proposition on the wall with André Kertész: The Master, opening December 4, 2026 and running through January 17, 2027. More than thirty signature works is not a sprawling museum survey, and frankly that may be the point. Kertész did not need grand scale to make his...

Continue Reading
Pennsylvania Housing Finds Its October Holding Pattern

Updated Category News Views 108

Pennsylvania's October housing numbers have the uneasy stillness of a pond before somebody throws a rock. The statewide median sales price sat at $315,000, exactly where it was in September, while sales barely cleared 10,400 and available listings kept inching higher. Nothing in that mix screams boom or bust. Frankly, that is the point: a market can look calm on the...

Continue Reading
Mason Adds Nonprofit Expertise to Institutional Bench

Updated Category News Views 110

Endowment committees rarely need more noise; they need somebody who has actually sat through the uncomfortable votes. Mason Investment Advisory Services has hired Rebecca “Becky” Farnsworth, CFA, as a senior investment consultant, and this looks like a practical addition rather than the usual chest-thumping personnel announcement. Her stated focus will be...

Continue Reading
Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Industrial Air Compressors: Fix, Rebuild, or Replace

Updated Category News Views 90

A compressor’s ugliest invoice is rarely the one from the service technician. It is the one nobody sees at first: a stalled production line, missed output, overtime, wasted electricity, and a maintenance crew chasing the same machine again next month. Pam Mahood of Waterloo, Iowa-based Compressed Air & Equipment Co. puts the decision where it belongs—not on the price...

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
ASA’s 2026 Grants Push Dermatology Into New Terrain

Updated Category News Views 80

Thirteen Small Bets With Serious Human Stakes Skin science rarely gets the splashy headlines, yet it touches a staggering number of people and carries some very stubborn unanswered questions. American Skin Association’s 2026 grant class puts 13 awards across skin cancer and dermatologic disease, with a noticeable willingness to follow newer clinical terrain rather than...

Continue Reading
Cash Flow Discipline Is Where Business Growth Gets Real

Updated Category News Views 73

A full order book can still leave a company gasping at payroll. That is the unglamorous point behind the Nov. 20, 2026, HelloNation piece featuring Kimberly Furrh of Furrh & Associates PC in Lawton, Oklahoma. Owners love to talk about sales because sales are visible, flattering and easy to celebrate. Cash is less theatrical. It is also the thing that keeps the lights on...

Continue Reading

Top 5 Most Recently Viewed Articles

Important Update for Sable Offshore Investors on Class Action

Updated Category News Views 261

Important Update for Sable Offshore Investors Sable Offshore Corp. (SOC), a prominent player in the oil transportation industry, is currently entangled in legal proceedings that have implications for its investors. If you've invested in SOC and suffered losses exceeding $100,000, there are critical updates you need to be aware of. Details on the Class Action Lawsuit A...

Continue Reading
Polestar Automotive Faces Lawsuit Over Financial Discrepancies

Updated Category News Views 353

Overview of the Legal Situation Concerning Polestar Automotive Recent events have brought attention to Polestar Automotive Holding UK PLC (NASDAQ: PSNY), a company known for its electric vehicles. A securities class action lawsuit has emerged, filed in the United States District Court for the District of New Jersey. This legal action is essential for individuals who...

Continue Reading
Quest Diagnostics' Q3 2024 Performance Boosts Annual Outlook

Updated Category News Views 257

Quest Diagnostics Reports Impressive Q3 2024 Financial Results Quest Diagnostics Incorporated (NYSE: DGX), a top provider of diagnostic information services, has shared its encouraging financial performance for the third quarter ended September 30, 2024. The company saw a notable increase in revenues, reaching $2.49 billion, representing an 8.5% rise compared to the...

Continue Reading
Castle Biosciences Receives NY Health Approval for TissueCypher

Updated Category News Views 118

Castle Biosciences Gains Approval for Revolutionary Test Castle Biosciences, Inc. (NASDAQ: CSTL), based in Friendswood, Texas, is charting a transformative course in healthcare with its recent approval from the New York State Department of Health for its TissueCypher Barrett’s Esophagus test. This achievement marks a significant milestone as TissueCypher stands out as...

Continue Reading
Oryzon Genomics to Conduct Insightful Virtual KOL Event

Updated Category News Views 147

Oryzon Genomics to Host Virtual KOL Event Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), renowned for its innovations in the field of epigenetics, has announced an engaging virtual KOL event aimed at addressing the complexities of Borderline Personality Disorder (BPD). This event, scheduled for a Wednesday at 12:00 pm ET, will be expertly moderated by Dr. Michael...

Continue Reading